ASH:NYE-Ashland Global Holdings Inc. (USD)

EQUITY | Specialty Chemicals | New York Stock Exchange

Last Closing

USD 66.03

Change

-1.13 (-1.68)%

Market Cap

USD 7.05B

Volume

0.78M

Analyst Target

USD 88.60
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Ashland Global Holdings Inc, formerly Ashland Inc is a speciality chemicals company. It provides products, services and solutions that meet customer needs throughout a variety of industries.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-19 )

Largest Industry Peers for Specialty Chemicals

Symbol Name Price(Change) Market Cap
APD Air Products and Chemicals Inc

-2.77 (-0.87%)

USD 74.55B
DLY DoubleLine Yield Opportunities..

-0.13 (-0.80%)

USD 27.84B
PPG PPG Industries Inc

+1.10 (+0.94%)

USD 27.32B
LYB LyondellBasell Industries NV

+0.11 (+0.14%)

USD 24.85B
ALB Albemarle Corp

-1.16 (-1.39%)

USD 9.90B
AXTA Axalta Coating Systems Ltd

+0.22 (+0.60%)

USD 8.17B
ALTM Arcadium Lithium plc

-0.01 (-0.17%)

USD 6.16B
ESI Element Solutions Inc

-0.46 (-1.67%)

USD 6.15B
AVNT Avient Corp

+0.07 (+0.16%)

USD 4.01B
FUL H B Fuller Company

+0.10 (+0.17%)

USD 3.33B

ETFs Containing ASH

EXIB:XETRA 12.83 % 0.00 %

N/A

N/A
TDXPEX:SW iShares TecDAX® UCITS ET.. 12.83 % 0.00 %

N/A

USD 5,933.97B
CB1TX:SW Lyxor 1 TecDAX (DR) UCITS.. 12.55 % 0.00 %

N/A

N/A
EGRE:XETRA 7.07 % 0.00 %

N/A

N/A
EGRO:PA BNP Paribas Easy ESG Grow.. 7.07 % 0.00 %

-0.01 (0.15%)

N/A
PCIG Litman Gregory Funds Trus.. 4.97 % 0.00 %

+0.01 (+0.15%)

USD 0.03B
EGRA:SW WisdomTree Eurozone Quali.. 4.37 % 0.00 %

N/A

N/A
FDHT Fidelity Covington Trust .. 3.60 % 0.00 %

-0.22 (0.15%)

USD 8.37M
EMOM:SW 3.59 % 0.00 %

N/A

N/A
IPXE:LSE First Trust IPOX® Europe.. 2.71 % 0.00 %

-0.20 (0.15%)

N/A
MTUSD:PA BNP Paribas Easy ECPI Glo.. 2.08 % 0.00 %

-0.02 (0.15%)

N/A
DOCG:LSE L&G Healthcare Breakthrou.. 1.87 % 0.00 %

-5.40 (0.15%)

USD 0.07B
DOCT:LSE L&G Healthcare Breakthrou.. 1.87 % 0.00 %

-0.04 (0.15%)

USD 0.07B
E908:F 0.00 % 0.00 %

N/A

N/A
EXS2:F 0.00 % 0.00 %

N/A

N/A
F751:F 0.00 % 0.00 %

N/A

N/A
E908:XETRA 0.00 % 0.00 %

N/A

N/A
EXS2:XETRA 0.00 % 0.00 %

N/A

N/A
F751:XETRA 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Specialty Chemicals) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -7.60% 19% F 10% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -7.60% 19% F 9% A-
Trailing 12 Months  
Capital Gain -28.37% 21% F 8% B-
Dividend Return 1.74% 58% F 29% F
Total Return -26.63% 24% F 8% B-
Trailing 5 Years  
Capital Gain -18.71% 22% F 28% F
Dividend Return 8.55% 37% F 25% F
Total Return -10.16% 22% F 20% F
Average Annual (5 Year Horizon)  
Capital Gain 7.27% 43% F 58% F
Dividend Return 8.72% 43% F 55% F
Total Return 1.45% 43% F 35% F
Risk Return Profile  
Volatility (Standard Deviation) 21.99% 81% B- 49% F
Risk Adjusted Return 39.66% 62% D 53% F
Market Capitalization 7.05B 58% F 72% C

Key Financial Ratios

  Ratio vs. Industry/Classification (Specialty Chemicals) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 18.08 65% 48%
Price/Book Ratio 1.18 74% 64%
Price / Cash Flow Ratio 6.63 67% 54%
Price/Free Cash Flow Ratio 61.73 4% 4%
Management Effectiveness  
Return on Equity 0.18% 26% 30%
Return on Invested Capital 4.56% 32% 43%
Return on Assets 1.94% 30% 46%
Debt to Equity Ratio 47.04% 75% 63%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low debt

The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Dividend Growth

This stock has shown top quartile dividend growth in the previous 5 years compared to its sector

What to not like:
Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Poor return on equity

The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector